HomeMarketTrading Hologic Inc. (HOLX) Stock is a good strategy

Trading Hologic Inc. (HOLX) Stock is a good strategy

RBC Capital Mkts raised the price target for the Hologic Inc. (NASDAQ:HOLX) stock to “a Sector perform”. The rating was released on December 07, 2022, according to finviz. The research report from UBS has initiated the stock to Neutral, with a price target set at $73. The stock was downgraded by BofA Securities, who disclosed in a research note on July 20, 2022, from Buy to Neutral and set the price objective to $75.

The latest trade, Performances and Moving Averages give us the following Picture

The share price of Hologic Inc. (NASDAQ:HOLX) dipped -0.05% to close Tuesday’s market session at $81.59, lower as compared to yesterday’s close. The stock price fluctuated between $80.08 and $81.72 throughout the trading session with the volume trading being 1734797 shares, which represented a significant variation when compared to the three months average volume of 1.65 million shares. The firm’s stock price fluctuated 2.68% within the last five trades and 8.18% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 16.13% in the last 6 months and 30.52% was added to its value over the previous 3 months. HOLX stock is trading at a margin of 4.51%, 7.34% and 13.32% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


As of the close of trading, HOLX deals in the Healthcare domain. The stock is trading -0.46 percent below its 52-week high and 36.48 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 20.94. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Hologic Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at 33.70 percent and the profit margin is 26.80 percent, and the company has reported a gross margin of 62.00 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $19.83 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Hologic Inc. (NASDAQ:HOLX) is 15.94. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 20.58. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 4.08 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 4.19, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Hellmann Elisabeth A, the SVP, Human Resources at Hologic Inc. (HOLX) has sold 1,649 shares of firm on Dec 14 at a price of $76.40 against the total amount of $0.13 million. In another inside trade, MACMILLAN STEPHEN P, Chairman, President and CEO of Hologic Inc. (NASDAQ:HOLX) sold 33,500 shares of the firm on Nov 30 for a total worth of $2.53 million at a price of $75.65. An inside trade which took place on Nov 15, Group Pres, Global Diagnostics of Hologic Inc. Thornal Kevin R sold 19,118 shares of firm against total price of $1.44 million at the cost of $75.32 per share.



Please enter your comment!
Please enter your name here

Recent Post